History of pharmacology Flashcards
Coined the term psychopharmacology
Macht and Mora
Reported on antipsychotic properties of the plant Rauwolfia serpentine
Sen and Bose
Discovered the use of lithium in mania
Cade
Showed the antipsychotic effects of chlorpromazine (previously used presurgically)
Delay and Deniker
Charpentier (two teams discovered independently)
First antidepressant to be discovered
Iproniazid
Reason iproniazid was discontinued
Hypertensive reactions
First synthesised chlorpromazine
Charpentier
Reintroduced clozapine
Kane
Developed the first SSRI zimelidine
Carlsson
First discovered the ‘cheese effect’ in MAOIs
Blackwell
Second antidepressant to market
Imipramine
Discovered the antidepressant use for imipramine
Kuhn
First to use ECT
Cerletti and Bini
Coined the term ‘antidepressant’
Lurie
First to use insulin shock therapy
Sakel
First to use frontal lobotomy for psychosis
Moniz
First to use metrazol shock therapy
Meduna
First SSRI to be developed
Zimeldine
Drug clozapine was synthesised from
Imipramine
Synthesised haloperidol and risperidone
Janssen
Year the first true antidepressant was discovered
1952
Year in which use of lithium in mania was discovered
1949
Years in which antipsychotic effects of chlorpromazine were discovered
1950-1952
Discovered the first benzodiazepine
Sternbach
First benzodiazepine to be discovered
Chlordiazepoxide
Year fluoxetine was marketed
1987
Coined the term ‘neuroleptic’
Delay
Study in 1988 which led to the widespread use of clozapine
Clozaril Collaborative Study Group Study #30
Results of the Clozaril Collaborative Study Group Study #30 in 1988 among patients with treatment resistant psychosis
30% of clozapine patients responded
4% of controls responded
Two large scale trials comparing first generation and second generation antipsychotics
CATIE
CUtLASS
Findings of the CATIE and CUtLASS studies
Second generation antipsychotics do not markedly differ from first generation antipsychotics in compliance, quality of life or effectiveness
Prevalence of metabolic syndrome among patients on antipsychotic in the CATIE trial
41%
Prevalence of metabolic syndrome among women on antipsychotics in the CATIE trial
52%
Prevalence of metabolic syndrome among men on antipsychotics in the CATIE trial
36%
Typical antipsychotic used in the CATIE trial
Perphenazine
Four atypical antipsychotics used in the CATIE trial
Olanzapine
Quetiapine
Risperidone
Ziprasidone
Year clozapine was first synthesised
1958
Reason clozapine was removed from market initially
Deaths from agranulocytosis
Type of antidepressant iproniazid was
Monoamine oxidise inhibitor
Type of antidepressant imipramine was
Tricyclic antidepressant
Reasons zimeldine was removed from market
Hypersensitivity reactions
Guillain-Barré syndrome
First scientist to quantify the placebo effect
Beecher
Associated with the use of valproate in mania
Bowden
Historically known as major tranquillisers
Antipsychotics
Historically known as minor tranquillisers
Benzodiazepines, barbiturates